This activity will review the current recommendations for screening (and the evidence behind them) for women-specific cancers. Dr. Friedman from the David Geffen School of medicine at UCLA will discuss up to date recommendations for screening for cervical, breast and ovarian cancers.
In this activity, Daniel Dunham, MD, reviews the pros and cons of screening for cancer, including what characteristics constitute a good screening test. He also discusses screening tests for some common cancer types and the current evidence for or against them.
Screening of the young athlete ranges from questionnaires to advanced cardiovascular diagnostic testing. The risk of disease in this population is quite low, yet each event has devastating consequences to families and communities. Prevention of even one event makes such clear moral sense that we feel obligated to employ any and all available tools that could possibly help do just that. It is important that we understand the tools available and that we use them effectively to save as many susceptible young lives as possible. It will be the goal of this talk to best understand the tools available with their advantages and disadvantages. We will also discuss the controversies surrounding these population health screening programs.
This talk will review the latest epidemiology of the HIV epidemic in New York. The 2015 update of the Department of Health and Human Services guidelines for first-line treatment regimens will be discussed, and a brief update of the latest data on treatment as prevention will be presented. The latest data addressing the advantages of the early initiation of antiretrovirals will also be presented. Finally, Dr. Scherer will discuss pre-exposure prophylaxis, or PrEP, and will provide practical guidance for the provision of PrEP in primary care practice.
Dr. Galluzzi will discuss the best approaches for screening seniors and the elderly for cancers and other diseases. She will explain the cost-benefit analyses a physician should employ before ordering screening tests in their geriatric patient population and discuss generating a practical strategy for determining the stopping age for cancer screening.
Colorectal cancer (CRC) is the 3rd most common cancer among men and women. The incidence is declining in large part due to increased screening and the detection and removal of pre-cancerous polyps. This activity will discuss the various options for screening for CRC and polyps, including advantages and limitations of different methods. Dr. Ghassemi will also discuss how to establish surveillance intervals based on findings at the index examination. The activity will focus on colonoscopy, which is considered the gold standard for screening, and the discussion will include potential reasons for missed polyps/interval cancers and quality indicators for colonoscopy. Newer screening methods, including stool DNA testing and colon capsule screening, will also be described.
Vitamin D and a variety of related conditions are ever present in the medical and lay literature. This activity will review the basics of Vitamin D metabolism, and will discuss what is known and not known about when to test and how to treat Vitamin D deficiency. Clinical outcomes discussed here include, cardiovascular disease, cancer and all cause mortality.
In the Unites States, it is estimated that there are 1.2 million persons living with HIV. This program will discuss appropriate screening patients for HIV infection and how to recognize signs and symptoms of acute retroviral syndrome. Treatment will also be discussed along with what factors influence the selection of an antiretroviral regimen and when pre-exposure prophylaxis is indicated.
In this activity, Dr. Dumanian will discuss the pathophysiology and symptoms of carpal tunnel syndrome and provide with the know-how to diagnose this condition in patients. Dr. Dumanian will also outline various treatment options, both surgical and non-surgical for the management of carpal tunnel syndrome.
This activity will address common ambulatory problems in Pulmonary Medicine. Dr. Fanta will discuss different patient scenarios such as the patient with chronic cough and in this context, touch upon the possibility of non-tuberculous mycobacterial pulmonary infection in the non-immunocompromised host. He will also discuss new guidelines for screening high-risk patients for lung cancer, with consideration of further evaluation of the incidentally discovered solitary pulmonary nodule; and finally, he will address when to test for latent pulmonary tuberculosis and treatment of the patient with positive test results (e.g., a positive PPD skin test).
In this activity, Lowell Schnipper, the Theodore and Evelyn Berenson Professor of Medicine at Harvard Medical School, uses several brief cases to highlight the appropriate follow-up and surveillance for patients following primary treatment for breast cancer and colorectal cancer.